Captopril patient counseling information: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Protected "Captopril patient counseling information": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)))
 
(2 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Captopril#Patient Counseling Information]]
{{Captopril}}
{{CMG}}; {{AE}} {{AM}}


==Information for Patients==
[[Category: Cardiovascular Drugs]]
 
[[Category: Drug]]
Patients should be advised to immediately report to their physician any signs or symptoms suggesting angioedema (e.g., swelling of face, eyes, lips, tongue, larynx and extremities; difficulty in swallowing or breathing; hoarseness) and to discontinue therapy. (See WARNINGS, Head and Neck Angioedema and Intestinal Angioedema.)
[[Category:ACE inhibitors]]
 
Patients should be told to report promptly any indication of infection (e.g., sore throat, fever), which may be a sign of neutropenia, or of progressive edema which might be related to proteinuria and nephrotic syndrome.
 
All patients should be cautioned that excessive perspiration and dehydration may lead to an excessive fall in blood pressure because of reduction in fluid volume. Other causes of volume depletion such as vomiting or diarrhea may also lead to a fall in blood pressure; patients should be advised to consult with the physician.
 
Patients should be advised not to use potassium-sparing diuretics, potassium supplements or potassium-containing salt substitutes without consulting their physician. (See PRECAUTIONS, General and Drug Interactions; ADVERSE REACTIONS.)
 
Patients should be warned against interruption or discontinuation of medication unless instructed by the physician.
 
Heart failure patients on captopril therapy should be cautioned against rapid increases in physical activity.
 
Patients should be informed that captopril should be taken one hour before meals (see DOSAGE AND ADMINISTRATION).
 
====Pregnancy====
Female patients of childbearing age should be told about the consequences of exposure to captopril during pregnancy. Discuss treatment options with women planning to become pregnant. Patients should be asked to report pregnancies to their physicians as soon as possible.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = CAPTOPRIL (CAPTOPRIL ) TABLET CAPTOPRIL TABLET [APOTEX CORP.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2c0f1ee3-b2b7-a1bc-059a-d65bea6cd0ef | publisher =  | date =  | accessdate =}}</ref>
 
==References==
{{Reflist}}
 
{{FDA}}
 
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]

Latest revision as of 18:37, 18 August 2015